Clinical phenotypes: variation of prevalences between countries
| Phenotype . | Czech Republic, no. patients (%) . | Germany, no. patients (%) . | Sweden, no. patients (%) . | United Kingdom, no. patients (%) . | P . |
|---|---|---|---|---|---|
| Polyclonal lymphocytic infiltration | 22 (54) | 21 (31) | 15 (12) | 37 (39) | < .001 |
| Infections only | 14 (34) | 27 (40) | 79 (61) | 36 (37) | < .001 |
| Autoimmunity | 12 (29) | 26 (38) | 35 (27) | 46 (48) | .02 |
| Enteropathy | 6 (15) | 7 (10) | 4 (3) | 12 (13) | .03 |
| Lymphoid malignancy | 0 | 4 (6) | 1 (0.8) | 5 (5) | .07 |
| Total | 41 | 68 | 129 | 96 |
| Phenotype . | Czech Republic, no. patients (%) . | Germany, no. patients (%) . | Sweden, no. patients (%) . | United Kingdom, no. patients (%) . | P . |
|---|---|---|---|---|---|
| Polyclonal lymphocytic infiltration | 22 (54) | 21 (31) | 15 (12) | 37 (39) | < .001 |
| Infections only | 14 (34) | 27 (40) | 79 (61) | 36 (37) | < .001 |
| Autoimmunity | 12 (29) | 26 (38) | 35 (27) | 46 (48) | .02 |
| Enteropathy | 6 (15) | 7 (10) | 4 (3) | 12 (13) | .03 |
| Lymphoid malignancy | 0 | 4 (6) | 1 (0.8) | 5 (5) | .07 |
| Total | 41 | 68 | 129 | 96 |